Breast Imaging Market

Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028

Report Code: MD 2554 Jun, 2023, by marketsandmarkets.com

The global breast imaging market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.6 billion by 2028, growing at a CAGR of 7.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The increasing number of research grants, rising focus on contrast-based diagnostic solutions, and rising awareness in developing economies are expected to drive the market during the forecast period.

Global Breast Imaging Market

Breast Imaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Breast Imaging Market

e- Estimated; p- Projected

Breast Imaging Market Dynamics

Driver: Rising incidence of breast cancer

The incidence of breast cancer is consistently increasing in developed as well as developing countries. This rising incident has increased a demand for technologically advanced instruments that focuses on early detection. The increasing number of breast cancer cases has forced governments across the globe to raise awareness regarding the importance of the early detection of breast cancer. According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women across the globe. Approximately 2,261,419 new cases of breast cancer were diagnosed in women, and 684,996 women died due to breast cancer across the world in the year 2020. Due to consistent rise in breast cancer cases each year, the demand for advanced breast imaging equipment is expected to grow in the coming years.

Restraint: High equipment costs

Recent technological advancements and newly added features have increased the cost of beast imaging equipment. There is a consistent rise in the cost of these systems with the introduction of automation with the help of AI. The new state-of-the-art equipment reduces reading time and provides users with accurate results but is often costly. In addition, there are recurrent expenses in the form of maintenance costs, which ultimately drive up the overall cost of ownership. Small-scale users such as diagnostic centers and breast care centers find it difficult to afford such equipment due to restricted budgets. This high cost has left users reliant on government and private research funding, which restricts market growth to a certain extent.

Opportunity: Growth potential in emerging countries

Developing economies offers high growth opportunities for key players operating in the breast imaging market. Countries such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa has large population base and offers a sustainable market for diagnostic imaging devices. The demand for diagnostic imaging has significantly increased in emerging economies due to the rising prevalence and growing awareness of breast cancer. The Indian government is focusing on providing the insurance scheme under the Ayushman Bharat program. The growth in the emerging economies is accompanied by favorable government and private policies to enhance access to diagnostic imaging, including the provision of reimbursement.

Challenge: Errors in breast cancer screening

Lower sensitivity, low reliability, painful compressions, and low patient tolerance are some of the potential limitations of various breast imaging modalities.  some invasive breast tumors detected by traditional mammography stop growing at certain stages. These tumors are considered non-life-threatening, and their detection through mammography leads to unnecessary need for overtreatment. X-ray mammography is a superior technology to avoid all these limitations and to obtain accurate results. However, in some countries like US the further testings are required to confirm the results. Hence, the accuracy of mammography in women with dense breasts becomes lower, leading to diagnosis errors. The limitations of the above mentioned imaging modalities are expected to hamper the adoption of these technologies.

By technology, the ionizing breast imaging technologies segment accounted for the largest share of the breast imaging industry in 2022

Based on technology, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. In 2022, the ionizing breast imaging technologies segment accounted for the largest market share. The rising use of advanced instruments in cancer research and the need for better sensitivity and early detection is driving the segment growth.

By product, the segment of the breast imaging industry to register significant growth in the near future

Based on product, the global breast imaging market is segmented into breast imaging systems, software & services, and accessories. Software & services to register the highest growth rate during the forecast period. The major factors responsible for the highest growth rate of this segment are the incorporation of new and advanced features in the software modules supporting accurate detection.

By end user, the segment accounted for the largest share of the breast imaging industry in 2022

Based on end user, the global breast imaging market is segmented into hospitals and clinics, diagnostic imaging centers, breast care centers, and other end users. In 2022, hospitals and clinics segment accounted for the largest market share. The highest share of this segment is attributed to the rising awareness and significant use of breast imaging equipment for the breast cancer detection. This is primarily attributed to the increasing number of breast diagnostic procedures performed in hospitals, growing inclination of hospitals toward automation and digitization of radiology patient workflow, and the rising adoption of technologically advanced systems in hospitals to improve the quality of patient care.

By region, North America is expected to be the largest market of the breast imaging industry during the forecast period

North America, comprising the US and Canada, accounted for the largest market share of the breast imaging market in 2022. Factors such as growing funding for research, and increasing applications in the healthcare sector, and the presence of major players in the region are driving market growth in North America. According to GLOBOCAN 2020, 281,591 new breast cancer cases were diagnosed in North America in 2020, and this number is expected to increase by 43,927 by 2030. Rapid growth in the geriatric population in the region is also resulting in an increasing number of breast cancer cases.

Breast Imaging Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2022, prominent players in the market are GE Healthcare (US), Hologic, Inc. (US), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan).

Scope of the Breast Imaging Industry

Report Metric 

Details 

Market Revenue in 2023

$4.4 billion

Projected Revenue by 2028

$6.6 billion

Revenue Rate

Poised to Grow at a CAGR of 7.7%

Market Driver

Rising incidence of breast cancer

Market Opportunity

Growth potential in emerging countries

This report has segmented the global breast imaging market to forecast revenue and analyze trends in each of the following submarkets

By Technology

  • Ionizing Breast Imaging Technologies
    • Full-Field Digital Mammography (FFDM)
    • Analog Mammography
    • 3D Breast Tomosynthesis
    • Contrast-Enhanced Mammography (CEM)
    • Positron Emission Mammography (PEM)
    • Positron Emission Tomography and Computed Tomography (PET-CT)
    • Molecular Breast Imaging/Breast-Specific Gamma Imaging (MBI/BSGI)
    • Cone-Beam Computed Tomography (CBCT)
  • Non-Ionizing Breast Imaging Technologies
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-Breast Ultrasound (AWBU)
    • Breast Thermography
    • Electric Impedance Tomography
    • Optical Imaging

By Product

  • Breast Imaging Systems
  • Software & Services
  • Accessories

By End User

  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments of Breast Imaging Industry

  • In 2021, Hologic launched a new ultrasound system, SuperSonic MACH 20. This system enhances diagnostic accuracy as well as efficiency. It provides users with improved image quality along with innovative imaging modes.
  • In 2020, GE HealthCare introduced the industry’s first contrast-enhanced guided biopsy solution for breast cancer patients. Serena Bright enables clinicians to access contrast guidance for conducting breast biopsy exams using the same mammography equipment.
  • In 2022, Siemens Healthcare GmbH expanded its ultrasound portfolio by launching refreshed Acuson family systems. These systems have enhanced clinical adaptability and can be used for routine purposes.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SEGMENTATION 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 LIMITATIONS 
    1.7 STAKEHOLDERS 
    1.8 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH 
          FIGURE 1 BREAST IMAGING MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 RECESSION IMPACT ANALYSIS 
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 MARKET SIZE ESTIMATION FOR BREAST IMAGING MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                                FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF HOLOGIC, INC.
                    2.3.1.2 Approach 2: Customer-based market estimation
                                FIGURE 7 BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION: BREAST IMAGING MARKET
                    2.3.1.3 Growth forecast
                    2.3.1.4 CAGR projections
                                FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.4 DATA TRIANGULATION APPROACH 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION 
    2.6 ASSUMPTIONS 
    2.7 RISK ASSESSMENT 
           2.7.1 RISK ASSESSMENT: BREAST IMAGING MARKET
    2.8 GROWTH RATE ASSUMPTIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 51)
    FIGURE 10 BREAST IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 BREAST IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 BREAST IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 BREAST IMAGING MARKET: GEOGRAPHIC SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 BREAST IMAGING MARKET OVERVIEW 
          FIGURE 14 RISING PREVALENCE OF BREAST CANCER TO DRIVE GROWTH
    4.2 EUROPE: MAMMOGRAPHY MARKET, BY TYPE 
          FIGURE 15 3D BREAST TOMOSYNTHESIS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN EUROPEAN MAMMOGRAPHY MARKET
    4.3 NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT 
          FIGURE 16 SOFTWARE AND SERVICES SEGMENT TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET DURING FORECAST PERIOD
    4.4 ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER 
          FIGURE 17 HOSPITALS AND CLINICS SEGMENT TO CONTINUE TO HOLD LARGEST SHARE IN ASIA PACIFIC MARKET
    4.5 GEOGRAPHIC SNAPSHOT OF BREAST IMAGING MARKET 
          FIGURE 18 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 BREAST IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing incidence of breast cancer
                                FIGURE 20 NUMBER OF NEW BREAST CANCER CASES IN 2020, BY KEY COUNTRY
                    5.2.1.2 Increasing public-private investments, funding, and grants
                    5.2.1.3 Growing awareness of early breast cancer detection
                    5.2.1.4 Technological advancements in breast imaging modalities
                    5.2.1.5 Growing geriatric population
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of breast imaging systems
                    5.2.2.2 Stringent regulatory approval procedures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential in emerging economies
                    5.2.3.2 Contract-based diagnostic solutions and mobile solutions
           5.2.4 CHALLENGES
                    5.2.4.1 Side effects of radiation exposure
                    5.2.4.2 Errors in breast cancer screening and diagnosis
                    5.2.4.3 Increasing adoption of refurbished imaging systems
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 1 BREAST IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 TRADE ANALYSIS FOR BREAST IMAGING EQUIPMENT 
          TABLE 2 IMPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 3 EXPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.5 PATENT ANALYSIS 
          FIGURE 21 TOP 10 PATENT APPLICANTS FOR BREAST IMAGING (JANUARY 2012–DECEMBER 2022)
          FIGURE 22 TOP 10 PATENT APPLICANTS FOR MAMMOGRAPHY (JANUARY 2012–DECEMBER 2022)
    5.6 ECOSYSTEM COVERAGE: PARENT MARKET 
    5.7 VALUE CHAIN ANALYSIS 
           5.7.1 RESEARCH & DEVELOPMENT
           5.7.2 MANUFACTURING & ASSEMBLY
           5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
                    FIGURE 23 BREAST IMAGING MARKET: VALUE CHAIN ANALYSIS
    5.8 SUPPLY CHAIN ANALYSIS 
           5.8.1 PROMINENT COMPANIES
           5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.8.3 END USERS
                    FIGURE 24 BREAST IMAGING MARKET: SUPPLY CHAIN ANALYSIS
    5.9 PRICING TREND ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE FOR MAJOR BREAST IMAGING EQUIPMENT
    5.10 TECHNOLOGY ANALYSIS 
    5.11 REGULATORY LANDSCAPE 
           5.11.1 NORTH AMERICA
                    5.11.1.1 US
                                 TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
                                 TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.11.1.2 Canada
                                 TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.11.2 EUROPE
           5.11.3 ASIA PACIFIC
                    5.11.3.1 Japan
                                 TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.11.3.2 China
                                 TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.11.3.3 India
    5.12 REIMBURSEMENT SCENARIO 
          TABLE 10 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN US (AS OF 2022)
    5.13 CASE STUDIES 
           5.13.1 TECHNOLOGICAL CHALLENGES
                     TABLE 11 CASE STUDY 1: BETTER VISUALIZATION OF BREAST IMAGES IN WOMEN WITH DENSE BREAST TISSUE
    5.14 KEY CONFERENCES AND EVENTS (2023–2024) 
          TABLE 12 BREAST IMAGING MARKET: LIST OF MAJOR CONFERENCES AND EVENTS
 
6 BREAST IMAGING MARKET, BY TECHNOLOGY (Page No. - 80)
    6.1 INTRODUCTION 
          TABLE 13 BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    6.2 IONIZING BREAST IMAGING TECHNOLOGIES 
          TABLE 14 IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.2.1 MAMMOGRAPHY
                    TABLE 15 MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 16 MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 17 NORTH AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 18 EUROPE: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 19 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 20 LATIN AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 21 MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                    TABLE 22 MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    6.2.1.1 Full-field digital mammography (FFDM)
                               6.2.1.1.1 Use of lower radiation doses to drive growth
                                              TABLE 23 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 24 NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 25 EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 26 ASIA PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 27 LATIN AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 28 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                              TABLE 29 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    6.2.1.2 Analog mammography
                               6.2.1.2.1 High spatial resolution and low installation cost to boost adoption
                                              TABLE 30 ANALOG MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 31 NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 32 EUROPE: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 33 ASIA PACIFIC: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 34 LATIN AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 35 ANALOG MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                              TABLE 36 ANALOG MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    6.2.1.3 3D breast tomosynthesis
                               6.2.1.3.1 3D breast tomosynthesis to witness highest growth in mammography market
                                              TABLE 37 3D BREAST TOMOSYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 38 NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 39 EUROPE: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 40 ASIA PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 41 LATIN AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 42 3D BREAST TOMOSYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                              TABLE 43 3D BREAST TOMOSYNTHESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    6.2.1.4 Contrast-enhanced mammography (CEM)
                               6.2.1.4.1 Affordability over breast MRI and improved diagnostic accuracy to drive growth
                                              TABLE 44 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 45 NORTH AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 46 EUROPE: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 47 ASIA PACIFIC: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 48 LATIN AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 49 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                              TABLE 50 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.2.2 POSITRON EMISSION MAMMOGRAPHY (PEM)
                    6.2.2.1 Higher sensitivity and accuracy to drive adoption
                                TABLE 51 POSITRON EMISSION MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 52 NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 53 EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 ASIA PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 LATIN AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 56 POSITRON EMISSION MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 57 POSITRON EMISSION MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.2.3 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
                    6.2.3.1 Combined scans from PET and CT offer more accurate results
                                TABLE 58 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 59 NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 60 EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 61 ASIA PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 62 LATIN AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 63 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 64 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.2.4 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
                    6.2.4.1 High sensitivity to drive growth
                                TABLE 65 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 66 NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 67 EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 68 ASIA PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 69 LATIN AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 70 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 71 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
                    6.2.5.1 CBCT segment to witness s                                TABLE growth during forecast period
                                TABLE 72 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 73 NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 74 EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 75 ASIA PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 76 LATIN AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 77 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 78 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    6.3 NON-IONIZING BREAST IMAGING TECHNOLOGIES 
                                TABLE 79 NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.3.1 BREAST ULTRASOUND
                    6.3.1.1 Rising awareness and easy availability of ultrasound devices for breast imaging to drive growth
                                TABLE 80 BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 81 NORTH AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 82 EUROPE: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 83 ASIA PACIFIC: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 84 LATIN AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 85 BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 86 BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.3.2 BREAST MRI
                    6.3.2.1 Technological advancements in breast MRI to drive growth
                                TABLE 87 BREAST MRI MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 88 NORTH AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 89 EUROPE: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 90 ASIA PACIFIC: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 91 LATIN AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 92 BREAST MRI MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 93 BREAST MRI MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.3.3 AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
                    6.3.3.1 AWBU helps spot small cancers in mammograms of dense breasts
                                TABLE 94 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 95 NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 96 EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 97 ASIA PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 98 LATIN AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 99 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 100 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.3.4 BREAST THERMOGRAPHY
                    6.3.4.1 Rising popularity due to reduced exposure to harmful radiation to boost adoption
                                TABLE 101 BREAST THERMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 102 NORTH AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 103 EUROPE: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 104 ASIA PACIFIC: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 105 LATIN AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 106 BREAST THERMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 107 BREAST THERMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.3.5 ELECTRIC IMPEDANCE TOMOGRAPHY
                    6.3.5.1 Affordability and quick results to drive growth
                                TABLE 108 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 109 NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 110 EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 111 ASIA PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 112 LATIN AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 113 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 114 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           6.3.6 OPTICAL IMAGING
                    6.3.6.1 High sensitivity, easy accessibility, and lower cost to support growth
                                TABLE 115 OPTICAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 116 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 117 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 119 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 120 OPTICAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
                                TABLE 121 OPTICAL IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
 
7 BREAST IMAGING MARKET, BY PRODUCT (Page No. - 141)
    7.1 INTRODUCTION 
          TABLE 122 BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    7.2 BREAST IMAGING SYSTEMS 
           7.2.1 SIGNIFICANT TECHNOLOGICAL DEVELOPMENTS TO FUEL GROWTH
                    TABLE 123 BREAST IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 SOFTWARE AND SERVICES 
           7.3.1 INTRODUCTION OF NOVEL IMAGING SOFTWARE TO SUPPORT GROWTH
                    TABLE 124 BREAST IMAGING SOFTWARE AND SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.4 ACCESSORIES 
           7.4.1 INCREASING ADOPTION OF BREAST IMAGING EQUIPMENT TO BOOST GROWTH
                    TABLE 125 BREAST IMAGING ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
 
8 BREAST IMAGING MARKET, BY END USER (Page No. - 146)
    8.1 INTRODUCTION 
          TABLE 126 BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
    8.2 HOSPITALS AND CLINICS 
           8.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST GROWTH
                    TABLE 127 BREAST IMAGING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION)
    8.3 DIAGNOSTIC IMAGING CENTERS 
           8.3.1 RISING NUMBER OF PRIVATE IMAGING CENTERS CONTRIBUTING TO GROWTH
                    TABLE 128 BREAST IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION)
    8.4 BREAST CARE CENTERS 
           8.4.1 INCREASING INCLINATION TOWARD BREAST CARE CENTERS OBSERVED IN DEVELOPED COUNTRIES
                    TABLE 129 BREAST IMAGING MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 130 BREAST IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
 
9 BREAST IMAGING MARKET, BY REGION (Page No. - 152)
    9.1 INTRODUCTION 
          TABLE 131 BREAST IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 25 NORTH AMERICA: BREAST IMAGING MARKET SNAPSHOT
          TABLE 132 NORTH AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 133 NORTH AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
          TABLE 134 NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 135 NORTH AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 136 NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 137 NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 138 NORTH AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US to dominate North American breast imaging market during forecast period
                                TABLE 139 US: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 140 US: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 141 US: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 142 US: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Increasing incidence of breast cancer and favorable government guidelines to support growth
                                TABLE 143 CANADA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 144 CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 145 CANADA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 146 CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
    9.3 EUROPE 
          TABLE 147 EUROPE: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 148 EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
          TABLE 149 EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 150 EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 151 EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 152 EUROPE: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 153 EUROPE: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Rising utilization of ionizing and non-ionizing imaging technologies to boost growth
                                TABLE 154 GERMANY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 155 GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 156 GERMANY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 157 GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Growing government initiatives and modernization of healthcare infrastructure fueling growth
                                TABLE 158 FRANCE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 159 FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 160 FRANCE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 161 FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Growing funding opportunities for supporting cancer research to drive growth
                                TABLE 162 UK: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 163 UK: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 164 UK: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 165 UK: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Evolving regulatory scenario for breast imaging and rising incidence of cancer to drive growth
                                TABLE 166 ITALY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 167 ITALY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 168 ITALY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 169 ITALY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Growing geriatric population to drive growth
                                TABLE 170 SPAIN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 171 SPAIN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 172 SPAIN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 173 SPAIN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 174 REST OF EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                    TABLE 175 REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 176 REST OF EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 177 REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 26 ASIA PACIFIC: BREAST IMAGING MARKET SNAPSHOT
          TABLE 178 ASIA PACIFIC: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 179 ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
          TABLE 180 ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 181 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 182 ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 183 ASIA PACIFIC: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 184 ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Rising breast cancer cases and presence of universal healthcare reimbursement scenario to fuel growth
                                TABLE 185 JAPAN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 186 JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 187 JAPAN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 188 JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Government initiatives for healthcare development to fuel growth
                                TABLE 189 CHINA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 190 CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 191 CHINA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 192 CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising government initiatives focused on improving female health to drive growth
                                TABLE 193 INDIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 194 INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 195 INDIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 196 INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Rising research funding and awareness campaigns to support growth
                                TABLE 197 AUSTRALIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 198 AUSTRALIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 199 AUSTRALIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 200 AUSTRALIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Rising government initiatives to drive growth
                                TABLE 201 SOUTH KOREA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 202 SOUTH KOREA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 203 SOUTH KOREA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 204 SOUTH KOREA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.4.6 REST OF ASIA PACIFIC
                    TABLE 205 REST OF ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                    TABLE 206 REST OF ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 207 REST OF ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 208 REST OF ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
          TABLE 209 LATIN AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 210 LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
          TABLE 211 LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 212 LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 213 LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 214 LATIN AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 215 LATIN AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Rising modernization of healthcare facilities to drive growth
                                TABLE 216 BRAZIL: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 217 BRAZIL: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 218 BRAZIL: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 219 BRAZIL: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Availability of advanced care and increasing awareness programs to fuel growth
                                TABLE 220 MEXICO: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                TABLE 221 MEXICO: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 222 MEXICO: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 223 MEXICO: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 224 REST OF LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                    TABLE 225 REST OF LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 226 REST OF LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 227 REST OF LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE GROWTH
                    TABLE 228 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                    TABLE 229 MIDDLE EAST & AFRICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 230 MIDDLE EAST & AFRICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 231 MIDDLE EAST & AFRICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 232 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 233 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 215)
     10.1 OVERVIEW 
     10.2 RIGHT TO WIN 
     10.3 STRATEGIES OF KEY PLAYERS 
             FIGURE 27 KEY DEVELOPMENTS IN BREAST IMAGING MARKET
     10.4 REVENUE SHARE ANALYSIS 
             FIGURE 28 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN BREAST IMAGING MARKET (2020–2022)
     10.5 MARKET SHARE ANALYSIS 
             FIGURE 29 GE HEALTHCARE HELD LEADING POSITION IN BREAST IMAGING MARKET IN 2022
             TABLE 234 BREAST IMAGING MARKET: DEGREE OF COMPETITION
     10.6 COMPANY EVALUATION MATRIX (2022) 
             10.6.1 VENDOR INCLUSION CRITERIA
             10.6.2 STARS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 EMERGING LEADERS
             10.6.5 PARTICIPANTS
                        FIGURE 30 BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX, 2022
     10.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 STARTING BLOCKS
             10.7.3 RESPONSIVE COMPANIES
             10.7.4 DYNAMIC COMPANIES
                        FIGURE 31 BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     10.8 COMPETITIVE BENCHMARKING 
             TABLE 235 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BREAST IMAGING MARKET
     10.9 COMPETITIVE SCENARIO AND TRENDS 
             10.9.1 PRODUCT LAUNCHES
                        TABLE 236 BREAST IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023
             10.9.2 DEALS
                        TABLE 237 BREAST IMAGING MARKET: DEALS, JANUARY 2020–MAY 2023
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 238 BREAST IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023
 
11 COMPANY PROFILES (Page No. - 228)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 GE HEALTHCARE (PART OF GENERAL ELECTRIC COMPANY)
                        TABLE 239 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             11.1.2 HOLOGIC, INC.
                        TABLE 240 HOLOGIC, INC.: COMPANY OVERVIEW
                        FIGURE 33 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
             11.1.3 SIEMENS HEALTHCARE GMBH
                        TABLE 241 SIEMENS HEALTHCARE GMBH: COMPANY OVERVIEW
                        FIGURE 34 SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT (2022)
             11.1.4 KONINKLIJKE PHILIPS N.V.
                        TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             11.1.5 FUJIFILM HOLDINGS CORPORATION
                        TABLE 243 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
                        FIGURE 36 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.6 CANON INC.
                        TABLE 244 CANON INC.: COMPANY OVERVIEW
                        FIGURE 37 CANON INC.: COMPANY SNAPSHOT (2022)
             11.1.7 AURORA HEALTHCARE US CORP.
             11.1.8 ALLENGERS
             11.1.9 DILON TECHNOLOGIES, INC.
             11.1.10 PLANMED OY
             11.1.11 DELPHINUS MEDICAL TECHNOLOGIES, INC.
             11.1.12 MICRIMA LIMITED
             11.1.13 CMR NAVISCAN
             11.1.14 METALTRONICA S.P.A.
             11.1.15 CAPERAY
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 KUB TECHNOLOGIES
             11.2.2 SONOCINÉ
             11.2.3 NP JSC AMICO
             11.2.4 QT IMAGING, INC.
             11.2.5 IMAGING DIAGNOSTIC SYSTEMS, INC.
             11.2.6 SENO MEDICAL
             11.2.7 ONCOVISION
             11.2.8 VILLA SISTEMI MEDICALI SPA
             11.2.9 TRIVITRON HEALTHCARE
             11.2.10 ISONO HEALTH, INC.
 
12 APPENDIX (Page No. - 269)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the breast imaging market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial breast imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the breast imaging market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Breast Imaging Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the breast imaging market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

  • Generating a list of major global players operating in the breast imaging market.
  • Mapping annual revenues generated by major global players from the technology segment (or nearest reported business unit/product category)
  • Revenue mapping of major players to cover a major share of the global market share, as of 2021
  • Extrapolating the global value of the breast imaging market industry

Breast Imaging Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global breast imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the breast imaging market was validated using top-down and bottom-up approaches.

Market Definition

Breast imaging plays a vital role in the early detection and screening of breast cancer. This market addresses the industry focusing on various technologies used for the detection, monitoring, and diagnosis of breast cancer-related complications. Technologies such as mammography, magnetic resonance imaging (MRI), ultrasound, molecular breast imaging (MBI), and positron emission tomography (PET) help healthcare professionals to visualize the internal structure of breasts and other surrounding tissues. Breast imaging equipment is primarily used in hospitals & clinics, diagnostic imaging centers, and breast care centers.

Key Stakeholders

  • Senior Management
  • End Users
  • R&D Department
  • Finance/Procurement Department

Objectives of the Study

  • To define, describe, and forecast the size of the breast imaging market based on technology, product, end user, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global breast imaging market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global breast imaging market.
  • To analyze key growth opportunities in the global breast imaging market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), Latin America (Brazil, Mexico, and the RoLA), and the Middle East & Africa
  • To profile the key players in the breast imaging market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global breast imaging market, such as product launches; agreements; expansions; and mergers & acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global breast imaging market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Rest of Europe breast imaging market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific breast imaging market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Latin American breast imaging market into Colombia, Chile, Argentina, and Peru, among others
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 2554
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback